company-logo

Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products primarily in Japan. It offers Urief and Urief OD tablets for the treatment of dysuria; Glufast, Glubes, and Marizev tablets for type 2 diabetes; Darbepoetin Alfa BS and Epoetin Alfa BS injections for the treatment of renal anemia; Beova tablets for overactive bladder treatment; P-TOL chewable tablets for treating hyperphosphatemia; and Minirin Melt OD tablets for nocturia due to nocturnal polyuria in males, central diabetes insipidus, and nocturnal enuresis resulted from decrease of urine osmolality. The company's products in pipeline include KPS-0373 that has completed Phase III clinical trial to treat spinocerebellar ataxia; CCX168, which has completed Phase III clinical trial for the treatment of microscopic polyangiitis and granulomatosis with polyangiitis; AJM300, which is in Phase III clinical trial to treat ulcerative colitis; R788 that is in Phase III clinical trial to treat chronic idiopathic thrombocytopenic purpura; and MR13A9, which is in Phase III clinical trial to treat uremic pruritus in dialysis patients. It is also developing KLH-2109 for treating endometriosis and uterine fibroids; KDT-3594 for the treatment of Parkinson's disease; Silodosin for dysuria associated with benign prostatic hyperplasia; Mitiglinide for type 2 diabetes mellitus; and Bedoradrine for the treatment of acute exacerbation of asthma. In addition, it develops and sells protein controlled and energy supply foods; and purchases and sells related materials, as well as offers system development and information processing, construction contracting, equipment and facility management, and information gathering and development support services. The company was formerly known as Kissei Yakuhin Kogyo Co., Ltd. and changed its name to Kissei Pharmaceutical Co., Ltd. in October 1964. The company was founded in 1946 and is headquartered in Matsumoto, Japan.

Kissei Pharmaceutical Dividend Announcement

Kissei Pharmaceutical announced a semi annually dividend of ¥45.00 per ordinary share which will be made payable on 2025-06-01. Ex dividend date: 2025-03-28
Kissei Pharmaceutical's trailing twelve-month (TTM) dividend yield is 2.39%

Kissei Pharmaceutical Dividend History

Ex-Div dateDividend amountDividend typePay date
2025-03-28¥45.00semi annually2025-06-01
2024-09-27¥45.00semi annually2024-12-03
2024-03-28¥41.00semi annually
2023-09-28¥41.00semi annually2023-12-04
2023-03-30¥40.00semi annually2023-06-23
2022-09-29¥40.00semi annually2022-12-02
2022-03-30¥28.00semi annually2022-06-24
2021-09-29¥28.00semi annually2021-12-02
2021-03-30¥27.00semi annually2021-06-25
2020-09-29¥27.00semi annually2020-12-03
2020-03-30¥26.00semi annually2020-06-29
2019-09-27¥26.00semi annually2019-12-05
2019-03-27¥25.00semi annually2019-06-26
2018-09-26¥25.00semi annually2018-12-06
2018-03-28¥24.00semi annually2018-06-28
2017-09-27¥24.00semi annually2017-12-06
2017-03-29¥23.00semi annually2017-06-29
2016-09-28¥23.00semi annually
2016-03-29¥22.00semi annually
2015-09-28¥22.00semi annually
2015-03-27¥21.00semi annually
2014-09-26¥21.00semi annually
2014-03-27¥20.00semi annually

Kissei Pharmaceutical Dividend per year

Kissei Pharmaceutical Dividend growth

Kissei Pharmaceutical Dividend Yield

Kissei Pharmaceutical current trailing twelve-month (TTM) dividend yield is 2.39%. Interested in purchasing Kissei Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:

Kissei Pharmaceutical Financial Ratios

P/E ratio14.86
PEG ratio-0.67
P/B ratio0.73
ROE5.01%
Payout ratio0.00%
Current ratio5.50
Quick ratio4.15
Cash Ratio1.36

Kissei Pharmaceutical Dividend FAQ

How much is the next Kissei Pharmaceutical dividend?
Kissei Pharmaceutical's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next Kissei Pharmaceutical dividend. The next Kissei Pharmaceutical dividend will be released in March, or September.
When is Kissei Pharmaceutical dividend paid?
Kissei Pharmaceutical pays dividends on a semi annually basis. The specific dates may vary each year but are generally around March, and September. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does Kissei Pharmaceutical pay?
The specific amount of Kissei Pharmaceutical dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Kissei Pharmaceutical's dividend history.
Does Kissei Pharmaceutical stock pay dividends?
Yes, Kissei Pharmaceutical does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Kissei Pharmaceutical's dividend history.
How much dividend does Kissei Pharmaceutical pay?
Kissei Pharmaceutical paid ¥86 in 2024, ¥81 in 2023, ¥68 in 2022, ¥55 in 2021, and ¥53 in 2020.
How often does Kissei Pharmaceutical pay dividends?
Kissei Pharmaceutical typically pays dividends on a semi annually basis. This means that dividends are usually distributed 2 times a year. The specific payout dates may vary each year but generally fall around March, and September.
What is Kissei Pharmaceutical's dividend yield?
The current dividend yield for Kissei Pharmaceutical is 2.39%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate Kissei Pharmaceutical's exact dividend yield.
When does Kissei Pharmaceutical go ex dividend?
Kissei Pharmaceutical's ex-dividend date for the latest dividend was on 2025-03-28. Kissei Pharmaceutical typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next Kissei Pharmaceutical dividend paid?
Kissei Pharmaceutical pays dividends on a semi annually basis, typically around March, or September, but the exact dates can vary each year.
Will Kissei Pharmaceutical increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether Kissei Pharmaceutical will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is Kissei Pharmaceutical dividend per share?
Kissei Pharmaceutical paid ¥86 per share in 2024 and ¥81 per share in 2023. The amount of dividend per share that Kissei Pharmaceutical pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is Kissei Pharmaceutical a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Kissei Pharmaceutical a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Kissei Pharmaceutical a dividend stock?
Yes, Kissei Pharmaceutical is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is Kissei Pharmaceutical a good dividend stock?
Whether Kissei Pharmaceutical is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. Kissei Pharmaceutical has a history of paying regular dividends, which can make it attractive to income-focused investors.

Other factors to consider when evaluating Kissei Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does Kissei Pharmaceutical pay dividends monthly?
Kissei Pharmaceutical typically pays dividends on a semi annually basis.
Does Kissei Pharmaceutical pay dividends quarterly?
Kissei Pharmaceutical currently pays dividends on a semi annually basis.
Has Kissei Pharmaceutical ever paid a dividend?
Yes, Kissei Pharmaceutical has a history of paying dividends to its shareholders. Kissei Pharmaceutical is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy Kissei Pharmaceutical dividend stocks?
To buy Kissei Pharmaceutical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.

Place an order: Use the brokerage's trading platform to place an order to buy Kissei Pharmaceutical stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does Kissei Pharmaceutical pay dividends 2024?
Kissei Pharmaceutical pays dividends on a semi annually basis. 2024 dividend payments are in 2025-06-01. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will Kissei Pharmaceutical increase its dividend in 2024?
Decisions regarding Kissei Pharmaceutical dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date Kissei Pharmaceutical dividend overview you can look into the above table of dividend history.
How Kissei Pharmaceutical dividend works?
The Kissei Pharmaceutical dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how Kissei Pharmaceutical's dividend process works:

1. Determination of Dividend: Kissei Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.

2. Dividend Declaration: Once the board approves a dividend, Kissei Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.

3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.

4. Payment Date: On the designated payment date, Kissei Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.

5. Tax Implications: Dividends received from Kissei Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are Kissei Pharmaceutical dividends paid?
Kissei Pharmaceutical dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:

1. Record Date: Kissei Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.

2. Payment Date: On the designated payment date, Kissei Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.

3. Currency: Kissei Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does Kissei Pharmaceutical pay dividends?
Kissei Pharmaceutical typically pays dividends on a semi annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does Kissei Pharmaceutical pay dividends?
The general pattern is that Kissei Pharmaceutical pays dividends around March, and September. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is Kissei Pharmaceutical dividend safe?
The safety of Kissei Pharmaceutical's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.

To assess the safety of Kissei Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.

It is recommended to review Kissei Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.